{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:54:19Z","timestamp":1791482059393,"version":"4.3.4"},"reference-count":162,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pancreatic cancer (PC) presents a significant therapeutic challenge due to its immunosuppressive tumor microenvironment (TME). Emerging evidence supports the efficacy of high-voltage electrical pulses (HVEPs) in PC treatment, leveraging dual benefits of pancreatobiliary duct integrity maintenance and immunogenicity activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>PubMed, Embase, Cochrane Library, and Web of Science were searched from January 2000 to January 2025. This review synthesizes recent advances in HVEPs for PC treatment, specifically focusing on clinical translation, mechanistic insights, and combinatorial strategies with other modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Findings:<\/jats:title>\n                    <jats:p>HVEPs induce immunogenic cell death and reprogram the TME, converting immunologically \u201ccold\u201d tumors to \u201chot.\u201d We also highlight the synergistic potential of combining HVEPs with surgery, chemotherapy, immunotherapy (notably for prolonging immune effects and activating abscopal responses), and nanomaterials (which enhance targeting, reduce toxicity, and augment efficacy). Current research must still address several outstanding issues in device engineering, mechanism exploration, designing new immunotherapy combinations, and developing nanomaterials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Further exploration of the mechanisms of HVEPs and the development of combination approaches based on HVEPs \u2013 particularly with immunotherapy and nanomaterials \u2013 holds significant promise for advancing personalized, precise, and systemic management of PC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003386","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:02:04Z","timestamp":1757412124000},"page":"1504-1527","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["High-voltage electrical pulses for pancreatic cancer treatment in the era of precision medicine"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1561-0031","authenticated-orcid":false,"given":"Wenyuan","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7672-8394","authenticated-orcid":false,"given":"Tian\u2019An","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"R1-20260518","doi-asserted-by":"crossref","first-page":"7\u201324","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"1729\u201354","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"3973\u201388","DOI":"10.2147\/IJN.S413496","article-title":"Advances and prospects in the treatment of pancreatic cancer","volume":"18","author":"Duan","year":"2023","journal-title":"Int J Nanomed"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"R5-20260518","doi-asserted-by":"crossref","first-page":"12681","DOI":"10.3390\/ijms241612681","article-title":"Locoregional therapies and remodeling of tumor microenvironment in pancreatic cancer","volume":"24","author":"De Grandis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R6-20260518","doi-asserted-by":"crossref","first-page":"254\u201372","DOI":"10.1148\/radiol.2020192190","article-title":"High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiology"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"223\u201331","DOI":"10.3748\/wjg.v29.i2.223","article-title":"Irreversible electroporation for the management of pancreatic cancer: current data and future directions","volume":"29","author":"Spiliopoulos","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R8-20260518","first-page":"e2100978","article-title":"Electrotherapies for glioblastoma","volume":"8","author":"Jenkins","year":"2021","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"R9-20260518","doi-asserted-by":"crossref","DOI":"10.70389\/PJS.100082","article-title":"Transparency in the reporting of artificial INtelligence \u2013 the TITAN guideline","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R10-20260518","doi-asserted-by":"crossref","first-page":"279\u201390","DOI":"10.1007\/BF01867861","article-title":"Permeability changes induced by electric impulses in vesicular membranes","volume":"10","author":"Neumann","year":"1972","journal-title":"J Membr Biol"},{"key":"R11-20260518","doi-asserted-by":"crossref","first-page":"841\u201345","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","article-title":"Gene transfer into mouse lyoma cells by electroporation in high electric fields","volume":"1","author":"Neumann","year":"1982","journal-title":"EMBO J"},{"key":"R12-20260518","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.3390\/cancers15133340","article-title":"Pulsed electric fields in oncology: a snapshot of current clinical practices and research directions from the 4th world congress of electroporation","volume":"15","author":"Campana","year":"2023","journal-title":"Cancers"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"136\u201362","DOI":"10.3390\/cells2010136","article-title":"Induction of cell death mechanisms and apoptosis by nanosecond Pulsed Electric Fields (nsPEFs)","volume":"2","author":"Beebe","year":"2013","journal-title":"Cells"},{"key":"R14-20260518","doi-asserted-by":"crossref","first-page":"629\u201340","DOI":"10.1002\/ijc.31071","article-title":"Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases","volume":"142","author":"Guo","year":"2018","journal-title":"Int J Cancer"},{"key":"R15-20260518","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3390\/cancers11122034","article-title":"Nanosecond pulsed electric fields induce endoplasmic reticulum stress accompanied by immunogenic cell death in murine models of lymphoma and colorectal cancer","volume":"11","author":"Rossi","year":"2019","journal-title":"Cancers"},{"key":"R16-20260518","doi-asserted-by":"crossref","first-page":"1755\u201368","DOI":"10.1007\/s10495-014-1041-9","article-title":"Nanosecond pulsed electric fields modulate the expression of Fas\/CD95 death receptor pathway regulators in U937 and jurkat cells","volume":"19","author":"Estlack","year":"2014","journal-title":"Apoptosis Int J Program Cell Death"},{"key":"R17-20260518","doi-asserted-by":"crossref","first-page":"107871","DOI":"10.1016\/j.bioelechem.2021.107871","article-title":"Cell death due to electroporation \u2013 a review","volume":"141","author":"Batista Napotnik","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"R18-20260518","first-page":"52\u201359","article-title":"Considering effects of nanosecond pulsed electric fields on proteins","volume":"103","author":"Beebe","year":"2015","journal-title":"Bioelectrochemistry Amst Neth"},{"key":"R19-20260518","doi-asserted-by":"crossref","first-page":"899722","DOI":"10.3389\/fonc.2022.899722","article-title":"Effect of pulsed field ablation on solid tumor cells and microenvironment","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"R20-20260518","doi-asserted-by":"crossref","first-page":"9\u201324","DOI":"10.1016\/j.canlet.2020.12.018","article-title":"Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer","volume":"502","author":"Sun","year":"2021","journal-title":"Cancer Lett"},{"key":"R21-20260518","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1038\/s41598-019-39433-6","article-title":"Histopathological and ultrastructural changes after electroporation in pig liver using parallel-plate electrodes and high-performance generator","volume":"9","author":"L\u00f3pez-Alonso","year":"2019","journal-title":"Sci Rep"},{"key":"R22-20260518","first-page":"79\u201389","article-title":"Molecular and histological study on the effects of electrolytic electroporation on the liver","volume":"125","author":"Lv","year":"2019","journal-title":"Bioelectrochemistry Amst Neth"},{"key":"R23-20260518","doi-asserted-by":"crossref","first-page":"108355","DOI":"10.1016\/j.bioelechem.2022.108355","article-title":"Acute ATP loss during irreversible electroporation mediates caspase independent cell death","volume":"150","author":"Razakamanantsoa","year":"2023","journal-title":"Bioelectrochemistry Amst Neth"},{"key":"R24-20260518","doi-asserted-by":"crossref","first-page":"1757\u201371","DOI":"10.1038\/s41401-025-01487-w","article-title":"Co-inhibition of RAGE and TLR4 sensitizes pancreatic cancer to irreversible electroporation in mice by disrupting autophagy","volume":"46","author":"Ye","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"R25-20260518","doi-asserted-by":"crossref","first-page":"150366","DOI":"10.1016\/j.cej.2024.150366","article-title":"An electro-ferroptotic nanoammunition enables image-guided, spatiotemporally controlled cancer ferroptosis induction via irreversible electroporation","volume":"487","author":"Han","year":"2024","journal-title":"Chem Eng J"},{"key":"R26-20260518","doi-asserted-by":"crossref","first-page":"123\u201348","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"R27-20260518","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-023-01813-y","article-title":"Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma","volume":"22","author":"Gautam","year":"2023","journal-title":"Mol Cancer"},{"key":"R28-20260518","doi-asserted-by":"crossref","first-page":"773\u2013800","DOI":"10.1016\/j.jconrel.2023.12.007","article-title":"Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy","volume":"365","author":"Dang","year":"2024","journal-title":"J Control Release"},{"key":"R29-20260518","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12943-023-01885-w","article-title":"Exploiting innate immunity for cancer immunotherapy","volume":"22","author":"Yi","year":"2023","journal-title":"Mol Cancer"},{"key":"R30-20260518","doi-asserted-by":"crossref","first-page":"604\u201323","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R31-20260518","doi-asserted-by":"crossref","first-page":"1129\u201342","DOI":"10.1016\/S2468-1253(23)00207-8","article-title":"The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy","volume":"8","author":"Hilmi","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R32-20260518","doi-asserted-by":"crossref","first-page":"4606\u201317","DOI":"10.1158\/1078-0432.CCR-21-3452","article-title":"Facts and hopes in immunotherapy of pancreatic cancer","volume":"28","author":"Bockorny","year":"2022","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"R33-20260518","doi-asserted-by":"crossref","first-page":"2175\u2013204","DOI":"10.7150\/thno.67530","article-title":"Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation","volume":"12","author":"Kwak","year":"2022","journal-title":"Theranostics"},{"key":"R34-20260518","doi-asserted-by":"crossref","first-page":"487\u2013500","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat Immunol"},{"key":"R35-20260518","article-title":"A guide to cell death pathways","author":"Yuan","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R36-20260518","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R37-20260518","doi-asserted-by":"crossref","first-page":"1714\u201326","DOI":"10.1158\/2326-6066.CIR-19-0101","article-title":"Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model","volume":"7","author":"Narayanan","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"R38-20260518","doi-asserted-by":"crossref","first-page":"1652532","DOI":"10.1080\/2162402X.2019.1652532","article-title":"Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation","volume":"8","author":"Scheffer","year":"2019","journal-title":"Oncoimmunology"},{"key":"R39-20260518","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41467-019-08782-1","article-title":"Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat Commun"},{"key":"R40-20260518","doi-asserted-by":"crossref","first-page":"54415\u201325","DOI":"10.1021\/acsami.0c15679","article-title":"Electric pulse responsive magnetic nanoclusters loaded with indoleamine 2,3-dioxygenase inhibitor for synergistic immuno-ablation cancer therapy","volume":"12","author":"Yu","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"R41-20260518","doi-asserted-by":"crossref","first-page":"2632\u201347","DOI":"10.1038\/s41423-021-00796-4","article-title":"Distinct roles but cooperative effect of TLR3\/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors","volume":"18","author":"Babikr","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R42-20260518","doi-asserted-by":"crossref","first-page":"1897295","DOI":"10.1080\/2162402X.2021.1897295","article-title":"The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer","volume":"10","author":"He","year":"2021","journal-title":"Oncoimmunology"},{"key":"R43-20260518","doi-asserted-by":"crossref","first-page":"1875638","DOI":"10.1080\/2162402X.2021.1875638","article-title":"Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer","volume":"10","author":"Yang","year":"2021","journal-title":"Oncoimmunology"},{"key":"R44-20260518","first-page":"2782\u2013801","article-title":"OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngeneic pancreatic cancer model","volume":"11","author":"Zhang","year":"2021","journal-title":"Am J Cancer Res"},{"key":"R45-20260518","doi-asserted-by":"crossref","first-page":"121762","DOI":"10.1016\/j.biomaterials.2022.121762","article-title":"Image-guided in situ cancer vaccination with combination of multi-functional nano-adjuvant and an irreversible electroporation technique","volume":"289","author":"Han","year":"2022","journal-title":"Biomaterials"},{"key":"R46-20260518","doi-asserted-by":"crossref","first-page":"e2200316","DOI":"10.1002\/smll.202200316","article-title":"Combination of metal-phenolic network-based immunoactive nanoparticles and bipolar irreversible electroporation for effective cancer immunotherapy","volume":"18","author":"Han","year":"2022","journal-title":"Small Weinh Bergstr Ger"},{"key":"R47-20260518","first-page":"e2105240","article-title":"Local release of TGF-\u03b2 inhibitor modulates tumor-associated neutrophils and enhances pancreatic cancer response to combined irreversible electroporation and immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"R48-20260518","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.3390\/cancers14153770","article-title":"Induction of bystander and abscopal effects after electroporation-based treatments","volume":"14","author":"Ruzgys","year":"2022","journal-title":"Cancers"},{"key":"R49-20260518","first-page":"1026\u201335","article-title":"Neutrophil membrane-coated nanoparticles for enhanced nanosecond pulsed electric field treatment of pancreatic cancer","volume":"39","author":"Zhao","year":"2022","journal-title":"Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group"},{"key":"R50-20260518","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1038\/s41467-023-39759-w","article-title":"Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"R51-20260518","doi-asserted-by":"crossref","first-page":"12915\u201332","DOI":"10.1021\/acsnano.3c05009","article-title":"Simultaneous delivery of dual inhibitors of DNA damage repair sensitizes pancreatic cancer response to irreversible electroporation","volume":"17","author":"Long","year":"2023","journal-title":"ACS Nano"},{"key":"R52-20260518","first-page":"e2302549","article-title":"Optimal irreversible electroporation combined with nano-enabled immunomodulatory to boost systemic antitumor immunity","author":"Peng","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"R53-20260518","first-page":"216514","article-title":"Nanosecond pulsed electric field stimulates CD103+ DC accumulation in tumor microenvironment via NK-CD103+ DC crosstalk","author":"Qian","year":"2023","journal-title":"Cancer Lett"},{"key":"R54-20260518","first-page":"101547","article-title":"Combination therapy of irreversible electroporation and cytokine-induced killer cells for treating mice bearing panc02 pancreatic-cancer xenografts","volume":"35","author":"Wang","year":"2023","journal-title":"Biochem Biophys Rep"},{"key":"R55-20260518","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1002\/ctm2.39","article-title":"T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer","volume":"10","author":"He","year":"2020","journal-title":"Clin Transl Med"},{"key":"R56-20260518","doi-asserted-by":"crossref","first-page":"2206\u201317","DOI":"10.1016\/j.immuni.2023.07.018","article-title":"Targeting innate immune pathways for cancer immunotherapy","volume":"56","author":"Cao","year":"2023","journal-title":"Immunity"},{"key":"R57-20260518","doi-asserted-by":"crossref","first-page":"1193040","DOI":"10.3389\/fimmu.2023.1193040","article-title":"Irreversible electroporation combined with chemotherapy and PD-1\/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"key":"R58-20260518","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3389\/fonc.2020.00843","article-title":"Patient derived xenografts expand human primary pancreatic tumor tissue availability for ex vivo irreversible electroporation testing","volume":"10","author":"Brock","year":"2020","journal-title":"Front Oncol"},{"key":"R59-20260518","doi-asserted-by":"crossref","first-page":"610\u201316","DOI":"10.1016\/j.surg.2020.04.057","article-title":"A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma","volume":"168","author":"O\u2019Neill","year":"2020","journal-title":"Surgery"},{"key":"R60-20260518","doi-asserted-by":"crossref","first-page":"4795\u2013807","DOI":"10.2147\/JIR.S331023","article-title":"Irreversible electroporation plus anti-PD-1 antibody versus irreversible electroporation alone for patients with locally advanced pancreatic cancer","volume":"14","author":"He","year":"2021","journal-title":"J Inflamm Res"},{"key":"R61-20260518","doi-asserted-by":"crossref","first-page":"2607\u201318","DOI":"10.1007\/s00432-017-2513-4","article-title":"Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III\/IV) pancreatic cancer: a promising treatment","volume":"143","author":"Lin","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"R62-20260518","first-page":"1643\u201349","article-title":"Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer","volume":"25","author":"Pan","year":"2020","journal-title":"J BUON Off J Balk Union Oncol"},{"key":"R63-20260518","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-020-00260-1","article-title":"Irreversible electroporation plus allogenic V\u03b39V\u03b42 T cells enhances antitumor effect for locally advanced pancreatic cancer patients","volume":"5","author":"Lin","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"R64-20260518","doi-asserted-by":"crossref","first-page":"827\u201354","DOI":"10.1038\/s41573-023-00746-x","article-title":"Strategies to therapeutically modulate cytokine action","volume":"22","author":"Leonard","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"R65-20260518","doi-asserted-by":"crossref","first-page":"e007530","DOI":"10.1136\/jitc-2023-007530","article-title":"New perspectives in cancer immunotherapy: targeting IL-6 cytokine family","volume":"11","author":"Soler","year":"2023","journal-title":"J Immunother Cancer"},{"key":"R66-20260518","doi-asserted-by":"crossref","first-page":"716\u201325","DOI":"10.1016\/j.trecan.2023.05.003","article-title":"Interleukin-10 in cancer immunotherapy: from bench to bedside","volume":"9","author":"Salkeni","year":"2023","journal-title":"Trends Cancer"},{"key":"R67-20260518","doi-asserted-by":"crossref","first-page":"e0166987","DOI":"10.1371\/journal.pone.0166987","article-title":"Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies","volume":"11","author":"Vogel","year":"2016","journal-title":"PloS One"},{"key":"R68-20260518","doi-asserted-by":"crossref","first-page":"800\u201306","DOI":"10.1245\/s10434-018-07144-3","article-title":"Evaluating the regulatory immunomodulation effect of Irreversible Electroporation (IRE) in pancreatic adenocarcinoma","volume":"26","author":"Pandit","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R69-20260518","doi-asserted-by":"crossref","first-page":"255\u201360","DOI":"10.1177\/153303460700600401","article-title":"Irreversible electroporation in medicine","volume":"6","author":"Rubinsky","year":"2007","journal-title":"Technol Cancer Res Treat"},{"key":"R70-20260518","doi-asserted-by":"crossref","first-page":"307\u201312","DOI":"10.1177\/153303460700600407","article-title":"The effect of irreversible electroporation on blood vessels","volume":"6","author":"Maor","year":"2007","journal-title":"Technol Cancer Res Treat"},{"key":"R71-20260518","doi-asserted-by":"crossref","first-page":"37\u201348","DOI":"10.1177\/153303460700600106","article-title":"Irreversible electroporation: a new ablation modality\u2013clinical implications","volume":"6","author":"Rubinsky","year":"2007","journal-title":"Technol Cancer Res Treat"},{"key":"R72-20260518","doi-asserted-by":"crossref","first-page":"223\u201331","DOI":"10.1007\/s10439-005-8981-8","article-title":"Tissue ablation with irreversible electroporation","volume":"33","author":"Davalos","year":"2005","journal-title":"Ann Biomed Eng"},{"key":"R73-20260518","doi-asserted-by":"crossref","first-page":"361\u201369","DOI":"10.1016\/j.jamcollsurg.2012.05.021","article-title":"Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma","volume":"215","author":"Martin","year":"2012","journal-title":"J Am Coll Surg"},{"key":"R74-20260518","doi-asserted-by":"crossref","first-page":"1613\u201321","DOI":"10.1016\/j.jvir.2012.09.012","article-title":"Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma","volume":"23","author":"Narayanan","year":"2012","journal-title":"J Vasc Interv Radiol"},{"key":"R75-20260518","doi-asserted-by":"crossref","first-page":"90\u201397","DOI":"10.1159\/000375323","article-title":"Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study","volume":"32","author":"Paiella","year":"2015","journal-title":"Dig Surg"},{"key":"R76-20260518","doi-asserted-by":"crossref","first-page":"1982\u201385","DOI":"10.1007\/s00464-016-5173-6","article-title":"A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas","volume":"31","author":"Stillstr\u00f6m","year":"2017","journal-title":"Surg Endosc"},{"key":"R77-20260518","first-page":"1401\u201306","article-title":"Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy","volume":"42","author":"M\u00e5nsson","year":"2016","journal-title":"Eur J Surg Oncol EJSO"},{"key":"R78-20260518","doi-asserted-by":"crossref","first-page":"342\u201348","DOI":"10.1016\/j.jvir.2016.10.023","article-title":"Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma","volume":"28","author":"Narayanan","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"R79-20260518","first-page":"2920\u201325","article-title":"A Single-institution experience with open irreversible electroporation for locally advanced pancreatic carcinoma","volume":"129","author":"Yan","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"R80-20260518","doi-asserted-by":"crossref","first-page":"585\u201397","DOI":"10.1148\/radiol.2016152835","article-title":"Ablation of locally advanced pancreatic cancer with percutaneous irreversible electroporation: results of the phase I\/II PANFIRE study","volume":"282","author":"Scheffer","year":"2017","journal-title":"Radiology"},{"key":"R81-20260518","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/MPA.0000000000000703","article-title":"Percutaneous irreversible electroporation for ablation of locally advanced pancreatic cancer: experience from a chinese institution","volume":"46","author":"Zhang","year":"2017","journal-title":"Pancreas"},{"key":"R82-20260518","doi-asserted-by":"crossref","first-page":"275\u201381","DOI":"10.21037\/jgo.2018.01.14","article-title":"Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma","volume":"9","author":"Leen","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"R83-20260518","doi-asserted-by":"crossref","first-page":"252\u201358","DOI":"10.1080\/00365521.2019.1575465","article-title":"Treatment of locally advanced pancreatic cancer with irreversible electroporation \u2013 a Danish single center study of safety and feasibility","volume":"54","author":"Flak","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"R84-20260518","doi-asserted-by":"crossref","first-page":"1024\u201331","DOI":"10.1016\/j.hpb.2018.12.004","article-title":"A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry","volume":"21","author":"Holland","year":"2019","journal-title":"HPB"},{"key":"R85-20260518","doi-asserted-by":"crossref","first-page":"2509\u201312","DOI":"10.21873\/anticanres.13371","article-title":"Percutaneous irreversible electroporation as first-line treatment of locally advanced pancreatic cancer","volume":"39","author":"M\u00e5nsson","year":"2019","journal-title":"Anticancer Res"},{"key":"R86-20260518","article-title":"Percutaneous irreversible electroporation in locally advanced and recurrent pancreatic cancer (PANFIRE-2): a multicenter, prospective, single-arm, phase II study","volume":"294","author":"Ah","year":"2020","journal-title":"Radiology"},{"key":"R87-20260518","doi-asserted-by":"crossref","first-page":"4348\u201359","DOI":"10.1245\/s10434-020-08782-2","article-title":"Electrochemotherapy with irreversible electroporation and FOLFIRINOX improves survival in murine models of pancreatic adenocarcinoma","volume":"27","author":"Bhutiani","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R88-20260518","doi-asserted-by":"crossref","first-page":"2771\u201375","DOI":"10.21873\/anticanres.14249","article-title":"Ultrasound-guided percutaneous irreversible electroporation for treatment of locally recurrent pancreatic cancer after surgical resection","volume":"40","author":"M\u00e5nsson","year":"2020","journal-title":"Anticancer Res"},{"key":"R89-20260518","doi-asserted-by":"crossref","first-page":"6885\u201395","DOI":"10.1007\/s00330-024-10613-x","article-title":"Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study","volume":"34","author":"Tasu","year":"2024","journal-title":"Eur Radiol"},{"key":"R90-20260518","first-page":"1349\u201355","article-title":"Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery","volume":"21","author":"Heger","year":"2021","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"key":"R91-20260518","doi-asserted-by":"crossref","first-page":"3225\u201331","DOI":"10.2169\/internalmedicine.0861-18","article-title":"Irreversible electroporation for nonthermal tumor ablation in patients with locally advanced pancreatic cancer: initial clinical experience in Japan","volume":"57","author":"Sugimoto","year":"2018","journal-title":"Intern Med"},{"key":"R92-20260518","doi-asserted-by":"crossref","first-page":"443\u201349","DOI":"10.1245\/s10434-012-2736-1","article-title":"Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival","volume":"20","author":"Martin","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R93-20260518","first-page":"S0039\u20136060(23)00609\u20138","article-title":"Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally advanced pancreatic cancer","author":"Stephens","year":"2023","journal-title":"Surgery"},{"key":"R94-20260518","doi-asserted-by":"crossref","first-page":"531\u201339","DOI":"10.1002\/jso.27310","article-title":"Infection reporting in patients undergoing irreversible electroporation of locally advanced pancreatic cancer","volume":"128","author":"Filson","year":"2023","journal-title":"J Surg Oncol"},{"key":"R95-20260518","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.ijsu.2015.06.049","article-title":"Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: our preliminary experience","volume":"21 Suppl 1","author":"Belfiore","year":"2015","journal-title":"Int J Surg Lond Engl"},{"key":"R96-20260518","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12032-017-0887-4","article-title":"Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancer","volume":"34","author":"Belfiore","year":"2017","journal-title":"Med Oncol"},{"key":"R97-20260518","doi-asserted-by":"crossref","first-page":"5564\u201375","DOI":"10.12998\/wjcc.v8.i22.5564","article-title":"Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer","volume":"8","author":"Ma","year":"2020","journal-title":"World J Clin Cases"},{"key":"R98-20260518","doi-asserted-by":"crossref","first-page":"3523769","DOI":"10.1155\/2022\/3523769","article-title":"Simultaneous gemcitabine and percutaneous CT-guided irreversible electroporation for locally advanced pancreatic cancer","volume":"2022","author":"Ma","year":"2022","journal-title":"J Oncol"},{"key":"R99-20260518","first-page":"269\u201373","article-title":"Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience","volume":"63","author":"Lambert","year":"2016","journal-title":"Neoplasma"},{"key":"R100-20260518","doi-asserted-by":"crossref","first-page":"448\u201359","DOI":"10.1016\/S2468-1253(24)00017-7","article-title":"MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial","volume":"9","author":"Timmer","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R101-20260518","doi-asserted-by":"crossref","first-page":"910\u201320","DOI":"10.1016\/j.surg.2014.06.058","article-title":"Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation","volume":"156","author":"Kwon","year":"2014","journal-title":"Surgery"},{"key":"R102-20260518","doi-asserted-by":"crossref","first-page":"1123\u201327","DOI":"10.1007\/s11517-016-1603-9","article-title":"Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma","volume":"55","author":"Marsanic","year":"2017","journal-title":"Med Biol Eng Comput"},{"key":"R103-20260518","doi-asserted-by":"crossref","first-page":"486\u201394","DOI":"10.1097\/SLA.0000000000001441","article-title":"Treatment of 200 locally advanced (Stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy","volume":"262","author":"Martin","year":"2015","journal-title":"Ann Surg"},{"key":"R104-20260518","doi-asserted-by":"crossref","first-page":"1736\u201343","DOI":"10.1245\/s10434-015-5034-x","article-title":"Single-institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients","volume":"23","author":"Kluger","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R105-20260518","doi-asserted-by":"crossref","first-page":"1442\u201350","DOI":"10.1002\/jso.27085","article-title":"Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer","volume":"126","author":"Thomas","year":"2022","journal-title":"J Surg Oncol"},{"key":"R106-20260518","doi-asserted-by":"crossref","first-page":"2734\u201343","DOI":"10.1245\/s10434-017-5900-9","article-title":"Induction chemotherapy followed by resection or irreversible electroporation in locally advanced pancreatic cancer (IMPALA): a prospective cohort study","volume":"24","author":"Vogel","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R107-20260518","first-page":"2571\u201378","article-title":"Margin ACcentuation for resectable pancreatic cancer using irreversible electroporation - results from the MACPIE-I study","volume":"47","author":"Kundalia","year":"2021","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"R108-20260518","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.3390\/cancers14225677","article-title":"Safety and efficacy of irreversible electroporation in locally advanced pancreatic cancer: an evaluation from a surgeon\u2019s perspective","volume":"14","author":"Shen","year":"2022","journal-title":"Cancers"},{"key":"R109-20260518","doi-asserted-by":"crossref","first-page":"581\u201389","DOI":"10.1016\/j.surg.2022.07.033","article-title":"Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer","volume":"173","author":"Martin","year":"2023","journal-title":"Surgery"},{"key":"R110-20260518","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12885-019-5607-3","article-title":"Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis","volume":"19","author":"He","year":"2019","journal-title":"BMC Cancer"},{"key":"R111-20260518","doi-asserted-by":"crossref","first-page":"4699\u2013710","DOI":"10.1002\/cam4.3119","article-title":"Comparison of combination therapies in the management of locally advanced pancreatic cancer: induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation","volume":"9","author":"He","year":"2020","journal-title":"Cancer Med"},{"key":"R112-20260518","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.3390\/cancers16233894","article-title":"Effectiveness and safety of irreversible electroporation when used for the ablation of stage 3 pancreatic adenocarcinoma: initial results from the DIRECT registry study","volume":"16","author":"Martin","year":"2024","journal-title":"Cancers"},{"key":"R113-20260518","doi-asserted-by":"crossref","first-page":"1657\u201368","DOI":"10.1245\/s10434-019-07261-7","article-title":"Systematic review of surgical and percutaneous irreversible electroporation in the treatment of locally advanced pancreatic cancer","volume":"26","author":"Moris","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R114-20260518","doi-asserted-by":"crossref","first-page":"230\u201336","DOI":"10.1016\/j.ijsu.2015.04.055","article-title":"Electrochemotherapy in locally advanced pancreatic cancer: preliminary results","volume":"18","author":"Granata","year":"2015","journal-title":"Int J Surg"},{"key":"R115-20260518","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/jcm10061305","article-title":"Clinical phase I\/II study: local disease control and survival in locally advanced pancreatic cancer treated with electrochemotherapy","volume":"10","author":"Izzo","year":"2021","journal-title":"J Clin Med"},{"key":"R116-20260518","doi-asserted-by":"crossref","first-page":"108576","DOI":"10.1016\/j.bioelechem.2023.108576","article-title":"Intraoperative electrochemotherapy of the posterior resection surface after pancreaticoduodenectomy: preliminary results of a hybrid approach treatment of pancreatic cancer","volume":"155","author":"\u010cebron","year":"2024","journal-title":"Bioelectrochemistry Amst Neth"},{"key":"R117-20260518","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.3390\/app10155163","article-title":"The first study of irreversible electroporation with calcium ions and chemotherapy in patients with locally advanced pancreatic adenocarcinoma","volume":"10","author":"Rudno-Rudzi\u0144ska","year":"2020","journal-title":"Appl Sci"},{"key":"R118-20260518","doi-asserted-by":"crossref","first-page":"e223135","DOI":"10.1148\/radiol.223135","article-title":"Outcomes following different thermal ablation strategies in patients with unresectable colorectal liver metastases","volume":"308","author":"Li","year":"2023","journal-title":"Radiology"},{"key":"R119-20260518","doi-asserted-by":"crossref","first-page":"817220","DOI":"10.3389\/fonc.2021.817220","article-title":"Optimizing patient selection for irreversible electroporation of locally advanced pancreatic cancer: analyses of survival","volume":"11","author":"Woeste","year":"2021","journal-title":"Front Oncol"},{"key":"R120-20260518","first-page":"811\u201317","article-title":"Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia","volume":"46","author":"Yang","year":"2020","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"R121-20260518","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.3390\/ijms24054381","article-title":"Irreversible electroporation in pancreatic cancer-an evolving experimental and clinical method","volume":"24","author":"Gajewska-Naryniecka","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R122-20260518","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.ijsu.2015.04.095","article-title":"Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases","volume":"21","author":"Tafuto","year":"2015","journal-title":"Int J Surg Lond Engl"},{"key":"R123-20260518","doi-asserted-by":"crossref","first-page":"351\u201361","DOI":"10.1097\/XCS.0000000000001291","article-title":"Irreversible electroporation and \u03b2-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma: a phase II study","volume":"240","author":"Martin","year":"2025","journal-title":"J Am Coll Surg"},{"key":"R124-20260518","doi-asserted-by":"crossref","first-page":"769\u201384","DOI":"10.1038\/s41577-021-00539-6","article-title":"Cellular networks controlling T cell persistence in adoptive cell therapy","volume":"21","author":"Chan","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R125-20260518","doi-asserted-by":"crossref","first-page":"840\u201348","DOI":"10.1038\/s41586-023-06525-3","article-title":"Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate V\u03b39V\u03b42 T cells","volume":"621","author":"Yuan","year":"2023","journal-title":"Nature"},{"key":"R126-20260518","doi-asserted-by":"crossref","first-page":"683\u201391","DOI":"10.1038\/nri3904","article-title":"\u03b3\u03b4 T cells in cancer","volume":"15","author":"Silva-Santos","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"R127-20260518","first-page":"925\u201339","article-title":"Cancer immunotherapy with \u03b3\u03b4 T cells: many paths ahead of us","volume":"17","author":"Kabelitz","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"R128-20260518","doi-asserted-by":"crossref","first-page":"2789\u2013805","DOI":"10.1200\/JCO.21.02616","article-title":"Immunologic strategies in pancreatic cancer: making cold tumors hot","volume":"40","author":"Ullman","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R129-20260518","doi-asserted-by":"crossref","first-page":"397\u2013413","DOI":"10.1038\/s41568-022-00462-5","article-title":"Context-dependent functions of pattern recognition receptors in cancer","volume":"22","author":"Man","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"R130-20260518","doi-asserted-by":"crossref","first-page":"37\u201350","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"R131-20260518","doi-asserted-by":"crossref","first-page":"e2300249","DOI":"10.1002\/adhm.202300249","article-title":"Vaccination of TLR7\/8 agonist-conjugated antigen nanoparticles for cancer immunotherapy","volume":"12","author":"Wang","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"R132-20260518","doi-asserted-by":"crossref","first-page":"196\u2013200","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"R133-20260518","doi-asserted-by":"crossref","first-page":"48\u201360","DOI":"10.1016\/j.molmed.2022.09.012","article-title":"Unlocking the potential of agonist antibodies for treating cancer using antibody engineering","volume":"29","author":"Jhajj","year":"2023","journal-title":"Trends Mol Med"},{"key":"R134-20260518","doi-asserted-by":"crossref","first-page":"160\u201377","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R135-20260518","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R136-20260518","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41419-018-0325-3","article-title":"Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer","volume":"9","author":"Hu","year":"2018","journal-title":"Cell Death Dis"},{"key":"R137-20260518","doi-asserted-by":"crossref","first-page":"33\u201348","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R138-20260518","doi-asserted-by":"crossref","first-page":"114357","DOI":"10.1016\/j.addr.2022.114357","article-title":"Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment","volume":"187","author":"Tarannum","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"R139-20260518","doi-asserted-by":"crossref","first-page":"193\u2013204","DOI":"10.1007\/s10439-013-0882-7","article-title":"Membrane-targeting approaches for enhanced cancer cell destruction with irreversible electroporation","volume":"42","author":"Jiang","year":"2014","journal-title":"Ann Biomed Eng"},{"key":"R140-20260518","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1038\/s41598-021-89661-y","article-title":"Combination of irreversible electroporation with sustained release of a synthetic membranolytic polymer for enhanced cancer cell killing","volume":"11","author":"Hanson","year":"2021","journal-title":"Sci Rep"},{"key":"R141-20260518","doi-asserted-by":"crossref","first-page":"477\u201394","DOI":"10.1038\/s41580-022-00571-x","article-title":"Revolutionizing DNA repair research and cancer therapy with CRISPR-Cas screens","volume":"24","author":"Awwad","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R142-20260518","doi-asserted-by":"crossref","first-page":"114621","DOI":"10.1016\/j.addr.2022.114621","article-title":"Image-guided drug delivery in nanosystem-based cancer therapies","volume":"192","author":"Priester","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"R143-20260518","doi-asserted-by":"crossref","first-page":"203\u201317","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R144-20260518","first-page":"1094\u2013110","article-title":"PGC1\u03b1 degradation suppresses mitochondrial biogenesis to confer radiation resistance in glioma","volume":"83","author":"Zhao","year":"2023","journal-title":"Cancer Res"},{"key":"R145-20260518","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","article-title":"Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma","volume":"22","author":"An","year":"2023","journal-title":"Mol Cancer"},{"key":"R146-20260518","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol Cancer"},{"key":"R147-20260518","doi-asserted-by":"crossref","first-page":"83\u201398","DOI":"10.1038\/s41571-022-00709-y","article-title":"Predicting tumour radiosensitivity to deliver precision radiotherapy","volume":"20","author":"Price","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R148-20260518","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"R149-20260518","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of pancreatic cancer: paving the way to better anticancer strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol Cancer"},{"key":"R150-20260518","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-024-02216-3","article-title":"Targeting KRAS: from metabolic regulation to cancer treatment","volume":"24","author":"Shi","year":"2025","journal-title":"Mol Cancer"},{"key":"R151-20260518","doi-asserted-by":"crossref","first-page":"1440\u201351","DOI":"10.1158\/2326-6066.CIR-20-0111","article-title":"Lactate-modulated immunosuppression of myeloid-derived suppressor cells contributes to the radioresistance of pancreatic cancer","volume":"8","author":"Yang","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"R152-20260518","doi-asserted-by":"crossref","first-page":"116490","DOI":"10.1016\/j.envres.2023.116490","article-title":"The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: bioresponisive nanostructures, phototherapy and targeted drug delivery","volume":"233","author":"Saadh","year":"2023","journal-title":"Environ Res"},{"key":"R153-20260518","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.3390\/cancers13153902","article-title":"Irreversible electroporation and nivolumab combined with intratumoral administration of a toll-like receptor ligand, as a means of in vivo vaccination for metastatic pancreatic ductal adenocarcinoma (PANFIRE-III). A phase-I study protocol","volume":"13","author":"Geboers","year":"2021","journal-title":"Cancers"},{"key":"R154-20260518","doi-asserted-by":"crossref","first-page":"1213\u201326","DOI":"10.1007\/s11912-023-01452-y","article-title":"New developments in image-guided percutaneous irreversible electroporation of solid tumors","volume":"25","author":"Yun","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"R155-20260518","doi-asserted-by":"crossref","first-page":"693\u2013700","DOI":"10.1001\/jamasurg.2022.2230","article-title":"Extended focal ablation of localized prostate cancer with high-frequency irreversible electroporation: a nonrandomized controlled trial","volume":"157","author":"Wang","year":"2022","journal-title":"JAMA Surg"},{"key":"R156-20260518","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41598-023-27605-4","article-title":"Nanosecond pulsed electric field suppresses growth and reduces multi-drug resistance effect in pancreatic cancer","volume":"13","author":"Szlasa","year":"2023","journal-title":"Sci Rep"},{"key":"R157-20260518","doi-asserted-by":"crossref","first-page":"108266","DOI":"10.1016\/j.bioelechem.2022.108266","article-title":"Single-cell analysis reveals nanosecond pulsed electric field ablation induced myeloid cells remodeling in pancreatic cancer","volume":"148","author":"Zhao","year":"2022","journal-title":"Bioelectrochemistry Amst Neth"},{"key":"R158-20260518","article-title":"Molecular dynamics study of protein-mediated electroporation of Kv channels induced by nsPEFs: advantages of bipolar pulses","author":"Guo","year":"2025","journal-title":"Biomacromolecules"},{"key":"R159-20260518","doi-asserted-by":"crossref","first-page":"1257\u201374","DOI":"10.1002\/cac2.12204","article-title":"Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review","volume":"41","author":"Yang","year":"2021","journal-title":"Cancer Commun"},{"key":"R160-20260518","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.gie.2022.11.004","article-title":"Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study","volume":"97","author":"So","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"R161-20260518","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.gie.2023.04.003","article-title":"Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)","volume":"98","author":"Napol\u00e9on","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"R162-20260518","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.cgh.2023.02.022","article-title":"Endoscopic ultrasound-guided radiofrequency ablation versus surgical resection for treatment of pancreatic insulinoma","volume":"21","author":"Crin\u00f2","year":"2023","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:22:11Z","timestamp":1779110531000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003386","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"2025-05-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}